The Role of Sugars in Fat Accumulation in the Liver

Recruiting N/A Interventional Study
Fatty Liver Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Male
Study type
Interventional
Purpose
Prevention
Participants needed
40 (estimated)
Sponsor
Institute for Clinical and Experimental Medicine · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This interventional study has 2 parts. In the part A of the project, we will determine how the acute changes in hepatic fat content (HFC) after high-fat load (150 g of fat) are affected by co-administration with three doses of glucose, fructose, and sucrose. HFC in non-obese and obese male volunteers will be measured by magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) bef…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Part A Inclusion Criteria: * male volunteers - 15 nonobese subjects (Body Mass Index (BMI) \< 30 kg/m2) and 15 obese subjects (BMI ˃ 30 kg/m2) * 18 - 70 years old Exclusion Criteria: * diabetes mellitus (fasting glucose above 7 mmol/l, 2-hour glucose after oGTT above 11.1 mmol/l, or antidiabetic…
Contacts

Jan Kovář, PhD

00420236053369

nkov@ikem.cz

CONTACT

Dita Pajuelo, PhD

00420236055348

diwa@ikem.cz

CONTACT